PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,347,053 | -11.2% | 1,577,108 | -7.2% | 3.03% | +12.4% |
Q2 2023 | $30,804,000 | -30.9% | 1,700,000 | +1.5% | 2.69% | -26.6% |
Q1 2023 | $44,555,000 | +37.6% | 1,675,000 | 0.0% | 3.67% | +46.3% |
Q4 2022 | $32,377,750 | +106.6% | 1,675,000 | +123.3% | 2.51% | +143.8% |
Q3 2022 | $15,668,000 | – | 750,000 | – | 1.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |